Navigation Links
EAU Research Foundation organizes meeting in Amsterdam highlighting translational research results

On 22 and 23 June 2009, the Prostate Cancer Translational Research in Europe (PCTRE) meeting will be held in the Beurs van Berlage in Amsterdam (NL). Translational research transforms scientific discoveries arising from laboratory, clinical or population studies into clinical applications to reduce cancer incidence, morbidity and mortality.

The European Association of Urology (EAU) provides an excellent forum to disseminate knowledge in specialised meetings. Therefore, the EAU Research Foundation has taken the initiative for this meeting.

The focus is on prostate cancer, the most common male malignancy in most European countries with 346,000 new cases diagnosed each year in Europe. Research efforts have increased steadily over the past two decades. "However the funding of cancer in research is very competitive", says Jack Schalken, Nijmegen Medical Centre (NL). It is, therefore, of particular importance that within the European Union based framework programme many prostate cancer consortia were funded in the last 5 years totaling approximately 40 million. "The translation of our understanding of prostate cancer development and progression to the bedside of the patient plays a pivotal role", Schalken, coordinator of PRIMA, one of the consortia, says. "Thus it is time to present the highlights of these efforts during this unique meeting".

Marion Bussemakers, EU project advisor at the Nijmegen Medical Centre, adds: "The European Union is keen to show the European public what is done with the money spent on prostate cancer research and to discuss the future of urologic research. Therefore Ms Maria Vidal, Scientific Officer, DG Research, European Commission, will be joining the meeting."

How will diagnostics and therapy of prostate cancer change in future? Diagnostics has already changed with the PCA3 marker. Final results from the European Randomised Study of Screening for Prostate Cancer, recently unveiled at the 24th Annual EAU Congress in Stockholm (SE), show that prostate cancer screening reduces deaths by 20 per cent. And there is more to come. "The Prima consortium," according to Prof. Jack Schalken, "has yielded three new lead compounds for the treatment of prostate cancer." These new compounds will be introduced in Amsterdam.

Top speakers will be recruited from 8 European Union framework programmes. Researchers, EU officials and representatives of the patient advocacy groups are invited to join the meeting. Furthermore, US based scientists will join to see how 'across the pond' collaboration can be improved. The faculty includes world-reknowned urologists such as Anders Bjartell, Freddie Hamdy, Peter Mulders and Per-Anders Abrahamsson.

The programme includes, among other things, the following highlights: Molecular genetics of prostate cancer, From molecular target to clinical molecular diagnostics, Targeted therapies and a round table discussion on 'Biomarkers in prostate cancer, where do we go?'

A press conference will be organised on Monday 22 June at 17:00 hours. Registration is free for media representatives.

For more information and registration, please visit


Contact: Lindy Brouwer
European Association of Urology

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
5. New research shows how chronic stress worsens neurodegenerative disease course
6. New research explores newborn in-hospital weight loss
7. Research may unlock mystery of autisms origin in the brain
8. Bipolar disorder relapses halved by Melbourne researchers
9. HIVs impact in Zimbabwe explored in new research
10. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
11. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, "Voices in ... that delves into an array of issues that are presently affecting Americans. Dedicated to ... dialogue, this show is changing the subjects consumers focus on, one episode at a ...
(Date:11/27/2015)... ... November 27, 2015 , ... The men ... prominent nonprofit healthcare organizations in the country. They have overseen financial turnarounds, shown ... helped advance the healthcare industry as a whole through their advocacy and professional ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients ... central Michigan, have come together on Thanksgiving Day to share the things that ... viewing on the Serenity Point YouTube channel, patients displayed what they wrote on ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... workshops to discuss bioavailability and the need to integrate dose form selection in ... collaboration with OBN, the membership organization supporting and bringing together the UK’s emerging ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack comes ... titles work with any font, giving users limitless opportunities to stylize and create ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... -- --> --> ... potential to save costs, improve treatment quality and accelerate ... exploited as yet. Here, particular emphasis is placed on ... tablet or directly at the patients, bedside. ... -->      (Photo: ) ...
(Date:11/27/2015)... -- Research and Markets ( ) has announced ... 2015-2019" report to their offering. ... the author the present scenario and growth prospects of ... the market size, the report considers revenue generated from ... and copper IUDs. The report forecasts the global intrauterine ...
(Date:11/26/2015)... 26, 2015 Un nuevo enfoque ... para el cáncer avanzado.   --> ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... . --> Clinical Cancer Research . ...
Breaking Medicine Technology: